Next to CA IX, a prognostic role of hexokinase 2 (HK2)—the speed limiting key enzyme of glycolysis—was found with a more than two-fold increased risk of tumor-related death due to a HK2 overexpression in OSCC (Berg T and co-authors, unpublished results). The gene discussed is CA9; the disease is neoplasm.